Objective: To examine the effect of induced fatigue on spatiotemporal gait parameters in persons with multiple sclerosis (PwMS) by using 6-min walk test (6MWT).
constitute one of the main causes of consultations on the basis of patients' perception of disability and quality of life (Larocca, 2011) .
The timed 25-foot walk test (T25FW) and the 6-min walk test (6MWT) are commonly used to assess gait for short and long distances, respectively (Bethoux & Bennett, 2011) . In the last decade, there have been increasingly rapid advances in the fields of kinematics, kinetics, and spatiotemporal gait parameters. Among the tools that have recently been introduced, mats equipped with pressure sensors (e.g., the GAITRite system) are being used frequently in the research and clinical fields. (van Uden & Besser, 2004) . These mats are able to detect gait disorders in persons with multiple sclerosis (PwMS) and allow one to describe gait biomechanics in greater detail (Givon, Zeilig, & Achiron, 2009; Hochsprung, Heredia-camacho, Castillo, Izquierdo, & Escuderouribe, 2014; Sosnoff, Weikert, Dlugonski, Smith, & Motl, 2011) . In this sense, spatiotemporal gait parameters in PwMS are well known: gait velocity, cadence, and step length tend to decrease and, in contrast, step time and the percentage of double support time, gait variability (Lizrova Preiningerova et al., 2015) , and asymmetry between right and left leg (Chung, Remelius, Van Emmerik, & Kent-Braun, 2008) tend to increase when neurological disability levels worsen.
Previous studies have observed changes in gait during the 6MWT (Goldman, Marrie, & Cohen, 2008; McLoughlin, Barr, Crotty, Sturnieks, & Lord, 2014; Socie, Motl, & Sosnoff, 2014 ). These studies have described a decrease in gait velocity (Goldman et al., 2008) , as well as in the mobility range of the hip, knee, and ankle of the most affected limb (McLoughlin et al., 2014) . In addition, they have shown an increase in gait variability, especially in cases of patients who require ambulatory assistance (Socie et al., 2014) .
Fatigue is a subjective symptom that is defined as a sense of exhaustion or a lack of energy that interferes with daily life activities (Multiple Sclerosis Council for Clinical Practice Guidelines, 1998).
There is no physiological measure or gold standard that allows us to objectively assess the quantity/amount of fatigue (Severijns et al., 2017) ; therefore, the use of self-administered questionnaires to quantify this symptom and to detect fluctuations has therefore been expanded (Learmonth et al., 2013) . Nevertheless, more specific concepts such as motor fatigue have also been suggested. Motor fatigue is defined as the gradual decrease in muscular strength that is produced while performing moderate physical activities such as gait and provokes both a loss of ambulatory ability and restrictions in participation (Phan-Ba et al., 2012) . Motor fatigue is commonly measured through objective tests that detect changes after voluntary muscle contractions (e.g., the changes in walking speed during a walking test; Severijns et al., 2017) .
The 6MWT requires submaximal muscular effort, especially in the context of the disease of MS. This test could induce changes in walking pattern, highlighting the existence of motor fatigue. The changes observed would be comparable with those that may appear during a normal day for PwMS (Savci et al., 2005) . The rationale of this study was based on fatigue induction using the 6MWT and the assessment of changes in spatiotemporal gait parameters. This will enable us to theorize about the compensatory strategies that are produced during gait performance by PwMS and to determine therapeutic strategies, as well as approaches used by physiotherapists. In line with this, a recent study found that when fatigue is induced by performing the 6MWT, PwMS experience a loss of standing balance, as well as of muscular strength in the lower limbs, resulting in motor loss and a higher risk of falling (McLoughlin et al., 2014) . Identifying these changes could consequently help us design training programmes that are specifically conceived to improve gait in MS patients.
Our hypothesis is that PwMS are likely to modify their gait pattern after the 6MWT, especially when neurological deficit is greater. The aim of our study was first to examine what effect 6MWT-induced fatigue has on spatiotemporal gait parameters.
Second, we aimed to reveal the associations between neurological deficits, perceived fatigue, and ambulatory capacity.
| METHODS

| Study design
We conducted a cross-sectional study with a control group.
| Participants
This study was conducted in the Neuro-physiotherapy Room in the Multiple Sclerosis Unit at University Hospital Virgen Macarena in Seville (Spain). The study was carried out from October 2014 to April 2015, between 8.00 a.m. and 8.00 p.m.
The inclusion criteria were ≥18 years old, a clinically definitive diagnosis of MS according to the revised McDonald criteria (Polman et al., 2011) and expanded disability status scale (EDSS) scores between 1.0 and 6.5 (Kurtzke, 1983) . This is the most widely used scale for assessing neurological deficits in PwMS and includes eight functional systems (pyramidal, sensory, cerebellar, brainstem, visual, cerebral, bowel and bladder, and other functions). It includes 10 levels of neurological deficit (0 = disability; 10 = death caused by MS). At EDSS 1.0, individuals have minimal disability, at EDSS 4.0, individuals are able to walk without aid or rest some 500 m, and at EDSS 6.5, individuals require two walking aids to walk about 20 m without resting.
Those with EDSS scores beyond 7.0 are unable to complete the 6MWT. (Kurtzke, 1983) . The three main clinical subtypes of MS were also included: relapsing-remitting (RR), primary progressive MS (PP), and secondary progressive (SP).
The exclusion criteria included the following: MS relapse during the 3 months before the study began, orthopaedic problems that affected gait, cardiovascular/respiratory comorbidities, pregnancy, and the use of fampridine. The control group was composed of a sample of 25 healthy persons (self-reported information) and family members and friends of MS participants. All participants signed an informed consent form. This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University Hospital Virgen Macarena.
| MATERIALS AND PROCEDURES
| Six-minute walk test
The 6MWT is a commonly used test that assesses physical function and ambulatory capacity during 6-min walking (Goldman et al., 2008; Kieseier & Pozzilli, 2012) . It is usually well-tolerated, easily performed and representative of submaximal effort equivalent to that required to perform activities of daily living (Wetzel, Fry, & Pfalzer, 2011) . The 6MWT has shown high reliability (ICC = 0.91-0.94) as well as sensitivity to changes in the functional status of PwMS and a strong negative correlation with EDSS scores (r = −0.73; p < 0.001; Goldman et al., 2008) . According to the procedure established by Goldman et al. (2008) , participants were instructed to "walk as fast as you comfortably can for 6 minutes, without running or jogging" in a 35 × 35 m square corridor (Sandroff et al., 2014) . Participants were informed of the time that had elapsed every minute, and those who usually used ambulatory assistance devices (e.g., a cane or a crutch) were allowed to use them. Distance was assessed using a digital measuring wheel (DigiRoller™ Plus-II).
| Fatigue
The modified fatigue impact scale (MFIS) is a self-administered and multidimensional questionnaire that assesses the fatigue experienced over the prior 4 weeks by using 21 items marked from 0 (never) to 4 (almost always). It differentiates the impacts on physical, cognitive, and psychosocial functioning, and each subscale score has a specific range: physical, 0 to 36 (MFIS-physical); cognitive, 0 to 40 (MFIS-cognitive); and psychosocial, 0 to 8 (MFIS-social). The total score ranges from 0 to 84, with 38 being used as the cut-off value for fatigue (Fisk, Pontefract, Ritvo, Archibald, & Murray, 1994) . This is a validated and reliable scale in PwMS (ICC = 0.795-0.909; Learmonth et al., 2013) .
The Spanish version has shown no cultural or linguistic differences compared with the original (Kos et al., 2005) .
| Gait analysis: Spatiotemporal parameters
Gait was assessed by using the GAITRite system. This system consists of an 8 × 0.61 m instrumented walkway system with 2,304 integrated sensors. It registers the pressure exerted and captures the spatial (distances) and temporal (time) parameters related to each footstep (Webster, Wittwer, & Feller, 2005) The gait parameters included in the analysis were gait velocity (cm/sec), cadence (step/min), step length (cm), base width (cm), step time (sec), stance time [% gait cycle (%GC)], double support time (%GC) and asymmetry; the differences between the legs were related to the step length (cm), step time (ms), and single support time (%GC).
| Testing procedure
First, an experienced neurologist (GIA) recorded the medical histories (demographic and clinical data) and updated the EDSS scores of each participant. Second, the participants who already met the inclusion and exclusion criteria were referred to the neuro-physiotherapy room for an approximately 1-hour visit to complete the MFIS questionnaire before performing the 6MWT, to perform the first gait analysis (T1), the 6MWT and a second gait analysis (T2). Pauses and breaks between each test were avoided in order to control for real changes induced by the 6MWT (Figure 1 ).
| Statistical analysis
Participants were divided into four subgroups according to their neurological disability levels: the mild (EDSS: 1.0-3.5), moderate (EDSS: 4.0-5.5), severe (EDSS: 6.0-6.5; Kurtzke, 1983) , and control groups.
When looking at the distanced walked, the MS participants were subdivided into fatigued (MFIS >38) and nonfatigued (MFIS <38) depending on their MFIS score. The Shapiro-Wilks test was used to check the normality of the outcome measures. The demographical and clinical characteristics are described using means (m) and standard deviations (SD) for the quantitative data and recounts (n) and proportions (%) for the qualitative data (gender, disease-modifying meds, MS type, and walking aids). Differences at baseline were examined using one-way analysis of variance or chi-square tests.
Differences in spatiotemporal gait parameters before and after 6MWT were calculated using paired-sample t tests (normal distributions) or Wilcoxon tests (non-normal distributions). In addition, the percentage of change for all the spatiotemporal gait parameters for every group was calculated {(T1 − T2)/T1 × 100}. Comparisons between EDSS and control groups were assessed using one-way analysis of variance or Kruskal-Wallis tests, including their post hoc multiple comparisons (Bonferroni or Mann-Whitney U test, respectively). Differences in distanced walked during the 6MWT between fatigued and nonfatigued groups were calculated using independent sample t test.
The association among neurological deficit levels (EDSS), perceived fatigue (MFIS-overall, MFIS-physical, MFIS-cognitive, and MFIS-psychosocial) and distances walked during the 6MWT were calculated using Pearson's correlation coefficient (r). The strength of this association was interpreted as follows: 0-0.19 (very weak), 0.2-0.39 (weak), 0.40-0.59 (moderate), 0.6-0.79 (strong), and 0.8-1 (very strong correlation; Armitage & Berry, 1994) . The level of p < 0.05 was considered as statistically significant. The data analysis was performed by using the SPSS statistical software (version 23.0).
| RESULTS
| Demographic and clinical data
Seventy-nine participants were included in this study and were divided according to the EDSS scores: the mild (n = 23, EDSS = 2.4 ± 0.8), moderate (n = 19, EDSS = 4.8 ± 0.5), severe (n = 12, EDSS = 6.1 ± 0.2), and healthy control groups (n = 25). The mean EDSS score of the MS groups of the study was 4.1 ± 1.6; the mean age was 43.1 ± 9.7 years; the mean disease duration was 10.3 ± 6.7 years; and 50 (63%) participants were females. No significant differences were found among the groups in terms of gender distribution, age, weight, or body mass index. In contrast, disease duration was longer in the severe (13.9 ± 5.4 years) versus the moderate (11.7 ± 7.8 years) and mild groups (7.3 ± 5.1 years; p = 0.009). The percentage of participants who used ambulatory assistance (a cane or crutch) was 83% in the severe group and 26% in the moderate group. The perceived fatigue level was significantly lower in the mild group (MFIS-overall = 37.6 ± 20.5; MFIS-physical = 17.4 ± 8.5) compared with both the moderate (MFIS-overall = 54.3 ± 17.2; MFISphysical = 27.4 ± 7.0) and severe groups (MFIS-overall = 53.6 ± 12.9; MFIS-physical = 27.2 ± 5.8; p < 0.05). No differences between moderate and severe groups were found (p > 0.05). The demographic characteristics and the neurological assessment and clinical information are provided in Table 1 . Table 2 shows the spatiotemporal gait parameters before and after the 6MWT. Statistical analysis showed significant intragroup differences in the moderate and severe group in the following parameters: gait velocity, cadence, and step length (p < 0.05) and step time, stance time, and double support time (p < 0.05). Regarding the spatiotemporal gait parameters after conducting the 6MWT, significant differences were observed between the four groups in velocity, cadence, step length, step time, stance time, and double support time (p < 0.001).
| Distance walked during 6MWT
| Gait parameters before and after performance of the 6MWT
The base width (cm) was higher in the severe (13.7 ± 5.2) compared with the mild (9.7 ± 2.2) and control (9.1 ± 2.7) groups (p = 0.005 and p < 0.001, respectively), and in the moderate (12.1 ± 3.4) compared with the control group (p = 0.012). Concerning the asymmetry parameters, step time (123.0 ± 97.0 ms) and single support (8.0 ± 3.4 %GC) were significantly higher in the severe group (p < 0.001) that in the rest of the groups.
Step length asymmetry (cm) was also higher in the severe (5.4 ± 3.5) group than that in the mild (1.9 ± 1.5) and control (1.6 ± 0.6) groups (p = 0.002 and p < 0.001, respectively).
The percentages of change in the spatiotemporal gait parameters after performance of 6MWT are provided in Figure 3 . No statistically significant changes were found in the mild or the control groups, with the exception of step time asymmetry, which decreased by 46.7% in the control group (p = 0.05). After performing the 6MWT gait velocity, FIGURE 1 Flow chart of the study. MS: multiple sclerosis; EDSS: expanded disability status scale; MFIS: modified fatigue impact scale; 6-min walk test (6MWT). cadence and step length were found to decrease significantly in the moderate and the severe groups (p < 0.05). In contrast, step time, stance time, and double support time increased in these groups (p < 0.05). Regarding the asymmetry parameters, we observed a tendency of them to decrease in the mild MS group; however, this tendency was not statistically significant, whereas single support asymmetry significantly increased in the moderate and severe groups and step time asymmetry only increased in the severe group (p < 0.05).
| DISCUSSION
This study compared changes in spatiotemporal gait parameters after performance of the 6MWT in a sample of PwMS, who were divided into three groups according to their disability levels, and a healthy control group. The results suggested that gait patterns are modified in PwMS with moderate-severe disability (EDSS 4.0-6.5) in comparison with those with mild disability (EDSS < 4.0) or with healthy persons. The tendency of these changes consists of decreases in gait velocity, cadence, and step length and increases in step time, double support, and stance time. In addition, we found a greater level of perceived fatigue in participants with EDSS 4.0-6.5 as measured by the MFIS. Our findings were consistent with those of previous studies that accurately described the spatiotemporal gait parameters and gait disorders of each MS stage (Comber, Galvin, & Coote, 2017) .
Fluctuations in gait that appear throughout the day or after moderate physical exercise are a common reality in healthcare contexts. This is one of the leading causes for consultations and one of the main challenges for physiotherapists (Larocca, 2011) . Along these lines, performing long walking tests, such as the 6MWT, will inform us about ambulatory capacity and at the same time be able to highlight the existence of motor fatigue (Goldman et al., 2008; McLoughlin et al., 2014) .
In our opinion, combining specific functional tests (posture, strength, balance) or instrumented gait analysis after performing the 6MWT (i.e., after inducing fatigue) will provide information regarding specific gait alterations, compensatory patterns, or neuromuscular deficits especially in moderate to severely disabled PwMS. aspects to the context of this research. We remarked that gait asymmetry parameters, that is, differences between right and left steps (time, length, and percentage of support), were greater when EDSS scores were higher and a tendency to increase when walking longer distances. Similar observations have shown that, in persons who have suffered from stroke, such changes in spatiotemporal gait parameters may be associated with both cardiorespiratory and muscular fatigue mechanisms that influence walking performance (Sibley, Tang, Patterson, Brooks, & McIlroy, 2009) . Curiously, the decrease in step time asymmetry observed in the healthy control group, after performing 6MWT, was not expected. We interpret these changes as a possible improvement in gait performance that was most likely influenced by the velocity reached (163 cm/s or 5.9 km/hr), which we consider faster than usual.
On the other hand, increases in gait asymmetry parameters have been associated with increased risk of falling and the level of perceived fatigue in PwMS (Kalron, 2015; Kalron, Frid, & Gurevich, 2014) . A possible explanation for this may be that PwMS have a less adaptable pattern of walking; in our study, this was reflected in the worsening of the spatiotemporal gait parameters after the 6MWT.
An inflexible gait pattern does not allow individual with MS to adequately adapt gait to meet the demands of the environment and the task (Kaipust, Huisinga, Filipi, & Stergiou, 2012) .
The changes observed after performing the 6MWT may be interpreted as compensatory strategies that appear after motor fatigue, usually in those with higher neurological deficit levels. In this Another important finding was that participants with mild impairment did not experience any modification in spatiotemporal gait parameters after performing the 6MWT. Nevertheless, they showed differences in gait velocity, cadence, step length, step time, percentage of double support time, and walked distance compared with the healthy participants. Recent findings have revealed a worsening of pulmonary function (Wetzel et al., 2011) and that the muscular strength of lower limbs is reduced (Citaker et al., 2013) in persons with minimal impairment (EDSS median = 1.5) compared with healthy subjects. This may explain the differences observed in our study between the mild group and the healthy group. Nevertheless, other studies have not reported fewer distances walked during performance of the Although some previous studies found no correlation between EDSS scores and the levels of perceived fatigue and that fatigue appears Step length asymmetry (cm) Control 1.8 ± 1.2 1.6 ± 0.6 0.183 Mild 1.9 ± 0.6 1.9 ± 1.5 0.927 Moderate 2.2 ± 1.9 2.8 ± 1.4 0.601 Severe 2.7 ± 0. Note. Spatiotemporal gait parameters for the mild (EDSS = 1.0-3.5), moderate (4.0-5.5), and severe (6.0-6.5) groups as well as for healthy controls before and after conducting the 6MWT. SD: standard deviation; IQR: interquartile range; GC: gait cycle.
p value between groups is a result of one-way analysis of variance or Kruskal-Wallis in asymmetry parameters. Another clinical implication suggested by our investigation is that interventions aimed to retraining gait in PwMS should consider spatiotemporal gait parameters and gait variations experienced after walks of relatively long duration, at least in those with moderate and severe MS (EDSS 4.0-6.5). Physiotherapists should take these alterations into consideration. Further researches on the relationship of these gait changes to the loss of balance and strength, the increase in energy expenditure, and, eventually, to the loss of efficacy and gait control are needed in order to target appropriate physiotherapeutic interventions. In this sense, Karpatkin et al. (2015) suggested that gait training programmes based on intermittent walking produce less tiredness or lack of energy and increase ambulatory capacity compared with continuous walking training programmes. 
| IMPLICATIONS FOR PHYSIOTHERAPY PRACTICE
Gait patterns are altered in PwMS with EDSS 4.0-6.5 after 6 min of walking. The changes experienced consisted of decreases in gait velocity, cadence, and step length and increases in step time, stance, and double support times, as well as in gait asymmetry parameters.
These gait changes were interpreted as compensatory strategies that appear after motor fatigue. Identifying these alterations may help determine personalized therapeutic objectives in physiotherapy.
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FIGURE 3
Percentage of change of spatiotemporal gait parameters after 6MTWT. Mild (EDSS = 1.0-3.5), Moderate (4.0-5.5), Severe (6.0-6.5) groups as well as for healthy controls after conducting the 6MWT. 
